Conference abstract · 30 Jun 2021
Conference abstractPublished 29 Aug 2018
(Not Yet Disclosed)
Pharmacology Institute of Sherbrooke, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While there has been a growing interest in understanding the pharmacological and physiological properties of cannabinoids in the last decades, analytical methodologies including sample preparations, remain one of the most challenging topics for their quantification in biological matrices. Moreover, the low sample weight or volume coupled to the complexity of biological samples (i.e. whole blood, plasma, etc.) could overwhelm the analyst expectations. In this study, we explored different possibilities to quantify a mixture of 8 natural phytocannabinoids present in biological samples (cannabinol, cannabigerolic acid, cannabinochromene, cannabigerol, cannbidiolic acid, tetrahydrocanninol, tetratracannabinolic acid and cannabidiol). The evaluation was carried-out using plasma and whole blood samples using different usual extraction protocols (solid phase extraction, liquid-liquid extraction, protein precipitation and blood spot sampling). Stability of tested molecules was also evaluated in several matrices (plasma, serum, ex vivo and pharmacokinetic profiles). The results showed a moderate matrix effect resulting by signal suppression (≤30%) and acceptable recoveries (≥60%) for most of the different tested extractions and matrices, except for whole blood when using acetonitrile for protein precipitation, which appears to be the less efficient approach for cannabinoid extraction, with a recovery lower than ≤40%. The applicability of tested methodologies was also applied for the determination of pharmacokinetic profiles and showed that dried blood spot sampling (DBS) could become an interesting alternative for in vivo studies. DBS is a rapid, acute and minimally invasive technic based on a single blood drop (10µL–25µL) that reduces handling and quantity of blood to be sampled, which consequently also reduces the cost of analysis. According to these aspects, DBS could become a reference methodology for in vivo pharmacokinetic experiments.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 5 Oct 2020
Disclosing Faults; correcting them; and revealing others Vital, but yet unnoticed Preventable Prophylactic Measures that must be implemented in battling against COVID-19’s Pandemic
Conference abstract · Oct 2020
Disclosing Faults; correcting them; and revealing others vital, but yet unnoticed preventable prophylactic measures that must be implemented in battling against COVID-19’s pandemic
Conference abstract · 8 Apr 2026
Sociological Anatomy of Healthcare: Nursesâ?? Intentions to Disclose Clinical Errors within the Context of Peer Surveillance in Ghana
Commentary · 30 Aug 2024
Disclosing Earth's Ancient Climate: A Study of Geological Evidence for Past Climate Change
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Lounès Haroune”
